Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection

Transplantation

Volumn 65, Issue 6, 1998, Pages 804-812

  Szabolcs, Matthias J ^a   Ravalli, Stefano ^a   Minanov, Oktavijan ^a   Sciacca, Robert R ^a   Michler, Robert E ^a   Cannon, Paul J ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PEROXYNITRITE;

ALLOGRAFT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; ENZYME INDUCTION; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MACROPHAGE FUNCTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; APOPTOSIS; BIOPSY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFLAMMATION; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0032571288     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803270-00007     Document Type: Article

References (53)

1. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation 1994; 89(5): 2421.
2. Maino G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995; 146: 3.
3. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223.
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456.
5. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445.
6. Pietsch MC, Polzar B, Stephan H, et al. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 1993; 12: 371.
7. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1.
8. Nicholson DW, All A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37.
9. Tewari M, Quan LT, O'Rourke K, et al. YAMA/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801.
10. Abrams JM, White K, Fessler LI, Steller H. Programmed cell death during Drosophila embryogenesis. Development 1993; 117: 29.
11. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992; 10: 267.
12. English HF, Kyprianou N, Isaacs JT. Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 1989; 15: 233.
13. Yamada T, Ohyama H. Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int J Radiat Biol 1988; 53: 65.
14. Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995; 96: 2247.
15. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150: 5080.
16. 2+ concentration and DNA fragmentation. Cancer Res 1992; 52: 1342.
17. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994; 75: 426.
18. Gottlieb RA, Berleson KO, Kloner RA, Bablor BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621.
19. Suzuki H, Wildhirl SM, Dudek RR, Narayan KS, Bailey GH, Bing RJ. Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages. Tissue Cell 1996; 28(1): 89.
20. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996; 74: 86.
21. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996; 335: 1190.
22. Laguens RP, Cabeza Meckert PM, Martino JS, Perrone S, Favaloro R. Identification of programmed cell death (apoptosis) in situ by means of specific labelling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J Heart Lung Transplant 1996; 15: 911.
23. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182.
24. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131.
25. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95: 2266.
26. Moncada S, Higgs A. The L-arginine:nitric oxide pathway. N Engl J Med 1993; 329: 2002.
27. Nathan C. Natural resistance and nitric oxide. Cell 1995; 82: 873.
28. Dawson TM, Dawson VL. Nitric oxide: actions and pathological roles. The Neuroscientist 1994; Preview Issue: 9.
29. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am J Physiol 1996; 271(Cell Physiol 40): C1424.
30. Yang X, Chowdhury N, Cai B, et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994; 94: 714.
31. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181: 63.
32. Cui S, Reichner JS, Mateo RB, Albina JE. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms. Cancer Res 1994; 54: 2462.
33. Szabolcs M, Michler RE, Yang X, et al. Apoptosis of cardiac myocytes during cardiac allograft rejection: relation to induction of nitric oxide synthase. Circulation 1996; 94: 1665.
34. Billingham ME, Cary NRB, Hamond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 587.
35. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J Cell Biol 1992; 119: 493.
36. Lewis NP, Tsao PS, Richenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996; 93: 720.
37. Balligand JL, Ungureanu D, Kelly RA, et al. Abnormal contractile function due to induction of nitric oxide synthase in rat cardiac myocytes follows exposure to activated macrophage conditioned medium. J Clin Invest 1993; 91: 2314.
38. Paulus WJ, Kätner S, Pujadas P, Shah AM, Drexler H, Vanderleyden M. Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft. Circulation 1997; 96: 3436.
39. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β. J Clin Invest 1995; 95: 677.
40. Wu C, Lovett M, Wong-hee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992; 54: 326.
41. Tian L, Noelle RJ, Lawrence DA. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 1995; 25: 306.
42. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4.
43. Larsen C, Elwwod D, Alexander D, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
44. Beckman JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 1994; 375: 81.
45. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992; 89: 3030.
46. Wink D, Kasprzak K, Maragos C, et al. DNA deaminating activity and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001.
47. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449.
48. Meβmer UK, Reed JC, Brhne B. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem 1996; 271: 20192.
49. Meβmer UK, Reimer DM, Reed JC, Brhne B. Nitric oxide induced poly(ADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl-2. FEBS Lett 1996; 384: 162.
50. Yang X, Szabolcs M, Minanov O, et al. CNI-1493 prolongs survival and reduces myocyte loss, apoptosis and inflammation during rat cardiac allograft rejection. J Cardiovasc Pharmacol (in press).
51. Nicholson DW. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat Biotech 1996; 14: 297.
52. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1996; 315: 21.
53. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 1996; 184: 2067.